- Home
- AGEN vs SATL Comparison
AGEN vs SATL Comparison
Compare AGEN & SATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGEN
- SATL
- Stock Information
- Founded
- AGEN 1994
- SATL 2010
- Country
- AGEN United States
- SATL Uruguay
- Employees
- AGEN N/A
- SATL N/A
- Industry
- AGEN Biotechnology: Biological Products (No Diagnostic Substances)
- SATL Radio And Television Broadcasting And Communications Equipment
- Sector
- AGEN Health Care
- SATL Technology
- Exchange
- AGEN Nasdaq
- SATL Nasdaq
- Market Cap
- AGEN 96.2M
- SATL 95.7M
- IPO Year
- AGEN 2000
- SATL N/A
- Fundamental
- Price
- AGEN $3.83
- SATL $2.88
- Analyst Decision
- AGEN Buy
- SATL
- Analyst Count
- AGEN 3
- SATL 0
- Target Price
- AGEN $10.50
- SATL N/A
- AVG Volume (30 Days)
- AGEN 399.9K
- SATL 709.3K
- Earning Date
- AGEN 03-13-2025
- SATL 08-15-2024
- Dividend Yield
- AGEN N/A
- SATL N/A
- EPS Growth
- AGEN N/A
- SATL N/A
- EPS
- AGEN N/A
- SATL N/A
- Revenue
- AGEN $160,427,000.00
- SATL $13,719,000.00
- Revenue This Year
- AGEN N/A
- SATL N/A
- Revenue Next Year
- AGEN $36.13
- SATL N/A
- P/E Ratio
- AGEN N/A
- SATL N/A
- Revenue Growth
- AGEN 59.00
- SATL 101.51
- 52 Week Low
- AGEN $2.50
- SATL $0.72
- 52 Week High
- AGEN $19.69
- SATL $5.49
- Technical
- Relative Strength Index (RSI)
- AGEN 65.58
- SATL 48.13
- Support Level
- AGEN $3.08
- SATL $2.80
- Resistance Level
- AGEN $3.29
- SATL $2.99
- Average True Range (ATR)
- AGEN 0.27
- SATL 0.31
- MACD
- AGEN 0.08
- SATL -0.10
- Stochastic Oscillator
- AGEN 94.84
- SATL 18.37
About AGEN Agenus Inc.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
About SATL Satellogic Inc.
Satellogic Inc is a provider of satellite imagery to governments and commercial customers globally. It geographically operates in North America, Europe, Asia and South America. It derives maximum revenue from Asia Pacific.